COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1448: Articles 14471-14480  | Next

Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.
Neary, M., Arshad, U., Tatham, L., Pertinez, H., Box, H., Rajoli, R. K., Valentijn, A., Sharp, J., Rannard, S. P., Biagini, G. A., Curley, P., Owen, A.
10.1101/2021.05.27.445500 — Posted: 2021-05-28
Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab
Gupta, A., Gonzalez-Rojas, Y., Juarez, E., Crespo Casal, M., Moya, J., Falci, D. R., Sarkis, E., Solis, J., Zheng, H., Scott, N., Cathcart, A. L., Hebner, C. M., Sager, J., Mogalian, E., Tipple, C., Peppercorn, A., Alexander, E., Pang, P. S., Free, A., Brinson, C., Aldinger, M., Shapiro, A. E.
10.1101/2021.05.27.21257096 — Posted: 2021-05-28
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada
Chung, H., He, S., Nasreen, S., Sundaram, M., Buchan, S. A., Wilson, S. E., Chen, B., Calzavara, A., Fell, D. B., Austin, P. C., Wilson, K., Schwartz, K. L., Brown, K. A., Gubbay, J., Basta, N. E., Mahmud, S. M., Righolt, C., Svenson, L. W., MacDonald, S. E., Janjua, N. Z., Tadrous, M., Kwong, J. C.
10.1101/2021.05.24.21257744 — Posted: 2021-05-28
Portable and label-free quantitative Loop-mediated Isothermal Amplification (qLAMP) for reliable COVID-19 diagnostics in 3 minutes: An Arduino-based detection system assisted by a pH microelectrode
Alvarez, M. M., Bravo-Gonzalez, S., Gonzalez-Gonzalez, E., Trujillo-de Santiago, G.
10.1101/2021.05.23.21256350 — Posted: 2021-05-28
Mortality audit of cancer patients with SARS-CoV-2 positivity or COVID-19
Kakati, K., Rahman, T., Barman, D., Bhattacharyya, M., Borthakur, B. B., Barman, R., Kalita, A., Kataki, A. C., Krishnatreya, M.
10.1101/2021.05.21.21257574 — Posted: 2021-05-28
Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India
Purkayastha, S., Kundu, R., Bhaduri, R., Barker, D., Kleinsasser, M., Ray, D., Mukherjee, B.
10.1101/2021.05.25.21257823 — Posted: 2021-05-27
Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variants
Morinaga, Y., Tani, H., Terasaki, Y., Nomura, S., Kawasuji, H., Shimada, T., Igarashi, E., Saga, Y., Yoshida, Y., Yasukochi, R., Kaneda, M., Murai, Y., Ueno, A., Miyajima, Y., Fukui, Y., Nagaoka, K., Ono, C., Matsuura, Y., Fujimura, T., Ishida, Y., Oishi, K., Yamamoto, Y.
10.1101/2021.05.25.21257828 — Posted: 2021-05-27
Fast Evaluation of Viral Emerging Risks (FEVER): A computational tool for biosurveillance, diagnostics, and mutation typing of emerging viral pathogens
Stromberg, Z. R., Theiler, J., Foley, B. T., Myers y Gutierrez, A., Hollander, A., Courtney, S. J., Deshpande, A., Martinez-Finley, E. J., Mitchell, J., Mukundan, H., Yusim, K., Kubicek-Sutherland, J. Z.
10.1101/2021.05.25.21257811 — Posted: 2021-05-27
SELP Asp603Asn and severe thrombosis in COVID-19 males: implication for anti P-selectin monoclonal antibodies treatment
Fallerini, C., Daga, S., Benetti, E., Picchiotti, N., Zguro, K., Catapano, F., Baroni, V., Lanini, S., Bucalossi, A., Marotta, G., Baldassarri, M., Fava, F., Beligni, G., Di Sarno, L., Alaverdian, D., Palmieri, M., Croci, S., Isidori, A. M., Furini, S., Frullanti, E., Multicenter Study, G.-C., Renieri, A., Mari, F.
10.1101/2021.05.25.21257803 — Posted: 2021-05-27
The Humoral Response to the BNT162b2 Vaccine in Hemodialysis Patients
Yau, K., Abe, K. T., Naimark, D. M., Oliver, M. J., Perl, J., Leis, J. A., Bolotin, S., Tran, V., Mullin, S., Shadowitz, E., Garnham-Takaoka, J., Quinn De Launay, K., Takaoka, A. T., Straus, S. E., McGeer, A. J., Chan, C. T., Colwill, K., Gingras, A.-C., Hladunewich, M. A.
10.1101/2021.05.24.21257425 — Posted: 2021-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).